-$77.8M
Net Activity
Institutions Holding
132
Popularity Rank
#3847
Avg Weight
0.14%
Total Value
$338.6M
132 institutions currently hold ENTA, with 68 net buyers and 56 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
56
Net Buying Institutions
68
Top 5 by Value
+$246.9M
Total Buy Value
$73.4M
Total Sell Value
68
Net Buyers
56
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Enanta Pharmaceuticals has set up an 'at-the-market' agreement with Jefferies LLC to sell up to $75 million of its common stock over time, at market prices. Under the deal, Jefferies will act as sales agent and earn a 3% commission on each share sold, but Enanta is not required to sell any shares at all.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter